The Risks of Subconscious Biases in Drug-Discovery Decision Making

Abstract

those participants who received ten as a reference value was 25%, while the median was 45% for those who received an initial number of 65 from the wheel [4]. In this article we will briefly describe four important psychological biases in decision making that could have an adverse impact on the drugdiscovery process. We will then illustrate the risks they pose at different stages of the pharmaceutical pipeline with practical examples. Finally, we will draw some conclusions and di scuss approaches for mitigating these risks. Four biases